Biotech

All Articles

' Clinical instinct' led FDA consultants to back Zevra's unusual condition med

.Zevra Rehabs' unusual disease drug seems to become on the pathway to authorization this fall after ...

Pfizer takes $230M hit after axing stopped working DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has blown a $230 million ...

AC Immune finds 'landmark' possible in Alzheimer's medication records

.After greater than twenty years of work on neurodegenerative ailments, Swiss biotech hvac Immune ca...

GSK falls ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has actually scrapped a stage 2 individual papillomavirus (HPV) injection coming from its pipel...

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.OS Therapies will definitely specify on the NYSE American supply swap today by means of a $6.4 mill...

ALX's waning CD47 feedback fee sends supply spiraling down

.ALX Oncology's stage 2 stomach cancer reaction price has diminished. After viewing its own CD47 blo...

Ionis centers eye illness coming from targets of Roche-partnered prospect after data disappoint

.One More of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of expectation...

Biogen's CEO said no risky sell 2023. He prepares to be vibrant

.While Biogen's pharma peers are looking for late-stage possessions with little bit of risk, CEO Chr...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has actually been actually a biotech in search of a pipeline after it ditched its ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned liberties to a very early Alzheimer's health condition program to Denali Therap...